Q: The German biopharmaceutical company Curevac, which trades on the Nasdaq,
plans a 5 million share sale. Is this a good sign? Your opinion.
Thank you.
Q: STLA Read a rather positive article in the Globe on this new company a few days ago. Is this one to consider or should one wait to see how it performs before taking even a small position?.
Q: Tencent shares took a tumble when its market value hit $1 trillion yesterday. Besides some profit taking, there was also warning by an adviser to China’s central bank indicating that excessive liquidity was creating asset bubbles. The prospect that China will tighten funding conditions also threatens to derail Tencent’s stock rally. Do you think it's time to sell the stock or continue to hold? Thanks!
Q: Garmin based in Switzerland has a vert strong balance sheet, sales have grown in 18 of the last 19 quarters. What do you think it's growth prospects are for 2021?
Q: Can you please advise BYDDF and BYDDY both the same company? If yes which one is better to buy and what is the difference between the two. Price is almost double on BYDDY.
Q: I’ve been attempting to diversify into EEM countries. The etf space doesn’t excite me but can you tell me your impressions about VIV? Do you believe it is worth the volatility given the dividend, etc.? THANKS!
Q: I am looking for a Canadian emerging market ETF that does not include China (or has only a small proportion) and considers ESG factors. My thinking is that China has already had a pretty good run but other emerging markets have more room for growth. So far I have found EMXC, XSOE, SUES and SUJS which might be suitable. Can you recommend an ETF? and Can you tell me if my thinking makes sense?
as usual, thanks for your help
(sorry if I posted this twice. my computer shut down as i was sending)
Q: Just like to get your thoughts on this company,do you think longer term it could be a disrupter in the credit card platform,also being up 450% in the last year and being thinly traded do you think its a bubble thanks have a great day
Q: Portfolio Analytics shows I still need 35% international funds in order to be balanced. I know it is more tax efficient to place ZEM and XEF in a non-registered account; however, I have room to place $15,000+ in my TFSA. My question is: Do you think it is wise to use TFSA for ZEM (given its potential for higher growth than ZCN) even though the foreign withholding fee is non-recoverable? Or, it is optimal that I find more growth stocks and add ZCN to my TFSA now then wait to purchase ZEM in a non-registered account in 3-6 months time?
Q: I sold DXJ and DXJS a year ago and have had seller’s remorse since the day I sold. Do you think buying these back at their current multiyear highs would be dumb? If you like Japan, would you today buy the same ETFs or do you have other ETFs (trading in US$ only) to suggest for my further study? If buying would you buy hedged or unhedged versions? I would be thankful for whatever number of symbols of Japan ETFs that you think might be fine for 3 to 5 years.
Q: I need some help in understanding some of the OTC Pink Sheet listings. While asking for a quote on Sika AG at RBCDI, two different options are presented. SXYAY at $27.52 USD and it has traded volume. SKFOF at $237.00 USD but has no traded volume for 15 Jan 21, and a very low avg vol.
Why the 2 diff "listings"? Different classes of shares?